' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 7 Researches
8.9
USERS' SCORE
Moderately Good
Based on 33 Reviews
7.7
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Vitamin D3 (as Cholecalciferol) (from Lanolin)
125 mcg (5,000 IU)
625%
Top Medical Research Studies
9
Vitamin D treatment reduces BPPV
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Directly explores vitamin D impact
We sought to understand the impact of severe vitamin D deficiency on benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. Previous studies showed a connection between low vitamin D levels and both the onset and recurrence of BPPV, but none had conclusively demonstrated that addressing this deficiency could lessen the recurrence of symptoms.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
Read More
9
Vitamin D3 reduces BPPV dizziness
Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults.
Effectively addresses vitamin D’s role
We conducted a double-blinded randomized controlled trial to explore the effects of Vitamin D3 on the recurrence of BPPV, a condition that causes dizziness in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Read More
8
Vitamin D3 helps BPPV dizziness
Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors.
Focused on vitamin D3's role
We conducted a study to understand how 1α-hydroxyvitamin D3 affects patients with benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. In this study, we selected 100 BPPV patients from the ENT Department of Anzhen Hospital—50 received daily doses of 0.25 µg 1α-hydroxyvitamin D3 in addition to standard care, while the other 50 only received the usual treatment.
After analyzing the bone mineral density (BMD) and vitamin D levels before and after treatment, we discovered some promising results. The BMD of both male and female patients taking vitamin D3 significantly improved following treatment, which was not the case for the control group. Furthermore, we found that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis played a crucial role in the effectiveness of BPPV treatment.
Our findings indicate that 1α-hydroxyvitamin D3 can effectively alleviate dizziness symptoms related to BPPV, making it a noteworthy addition to standard treatment protocols. This study highlights the importance of vitamin D levels in managing BPPV and suggests further exploration into its benefits for those suffering from dizziness.
After analyzing the bone mineral density (BMD) and vitamin D levels before and after treatment, we discovered some promising results. The BMD of both male and female patients taking vitamin D3 significantly improved following treatment, which was not the case for the control group. Furthermore, we found that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis played a crucial role in the effectiveness of BPPV treatment.
Our findings indicate that 1α-hydroxyvitamin D3 can effectively alleviate dizziness symptoms related to BPPV, making it a noteworthy addition to standard treatment protocols. This study highlights the importance of vitamin D levels in managing BPPV and suggests further exploration into its benefits for those suffering from dizziness.
Read More
Most Useful Reviews
9.5
Dizziness relieved
I've been taking it for four months. The capsules are easy to swallow, and I’m addressing my vitamin D3 deficiency. Dizziness has passed, though my joints still crunch. I recommend 5000 IU D3 for those with low levels.
Read More
9.5
Dizziness completely gone
In my late fifties and not seeing enough sun in Singapore, I initially tried a lower dose of vitamin D with no results. After switching to 5000 IU, my dizziness completely disappeared and my joints feel better.
Read More
0
Headaches triggered
This vitamin caused me a terrible headache, tachycardia, and dizziness. I switched to Vitamin Solaray D3 (5000) + K2 and experienced no side effects. Previously, I had no issues with D3 from California Nutrition.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 7 Researches
8.9
9.5
Vitamin D reduces dizziness recurrences
Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants.
Supplementation impact on dizziness
We explored how vitamin D3, coupled with antioxidant supplements, can help prevent recurrent cases of benign paroxysmal positional vertigo (BPPV), a common type of dizziness. In this multicentric trial involving 128 patients who experienced frequent episodes of BPPV, we organized participants into three groups based on their vitamin D levels and treatment.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
Read More
9.5
Vitamin D3 reduces dizziness recurrences
The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study.
Vitamin D's effect on BPPV
We explored how normalization of vitamin D levels may impact the recurrence of dizziness caused by benign paroxysmal positional vertigo (BPPV). This case-control study included patients with a history of BPPV who had low serum vitamin D levels. We divided participants into two groups: one received additional vitamin D3, while both groups underwent Epley rehabilitation therapy.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
Read More
9
Vitamin D3 reduces BPPV dizziness
Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults.
Effectively addresses vitamin D’s role
We conducted a double-blinded randomized controlled trial to explore the effects of Vitamin D3 on the recurrence of BPPV, a condition that causes dizziness in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Read More
9
Vitamin D aids BPPV treatment
Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study.
Study highlights vitamin D's benefits.
We investigated the impact of vitamin D supplementation on dizziness, specifically in individuals suffering from benign paroxysmal positional vertigo, commonly known as BPPV. Through a clinical study, we closely examined a group of patients diagnosed with BPPV, assessing their dizziness intensity using a simple scoring system.
Our findings highlighted that vitamin D deficient patients, who received weekly doses of vitamin D alongside rehabilitation, experienced a prolonged improvement in their vertigo symptoms compared to those who did not receive the vitamin. While both groups showed significant reduction in dizziness after two months, the benefits for those who had vitamin D supplementation remained stable even at six months’ follow-up, while the non-treated group saw a return of their symptoms to previous levels.
This suggests that correcting vitamin D deficiency not only plays a beneficial role in managing BPPV but also enhances the effectiveness of traditional rehabilitation methods, like the Epley maneuver, used in treating this condition. Overall, our observations point to the importance of checking vitamin D levels in patients who frequently experience BPPV for better treatment outcomes.
Our findings highlighted that vitamin D deficient patients, who received weekly doses of vitamin D alongside rehabilitation, experienced a prolonged improvement in their vertigo symptoms compared to those who did not receive the vitamin. While both groups showed significant reduction in dizziness after two months, the benefits for those who had vitamin D supplementation remained stable even at six months’ follow-up, while the non-treated group saw a return of their symptoms to previous levels.
This suggests that correcting vitamin D deficiency not only plays a beneficial role in managing BPPV but also enhances the effectiveness of traditional rehabilitation methods, like the Epley maneuver, used in treating this condition. Overall, our observations point to the importance of checking vitamin D levels in patients who frequently experience BPPV for better treatment outcomes.
Read More
9
Vitamin D treatment reduces BPPV
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Directly explores vitamin D impact
We sought to understand the impact of severe vitamin D deficiency on benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. Previous studies showed a connection between low vitamin D levels and both the onset and recurrence of BPPV, but none had conclusively demonstrated that addressing this deficiency could lessen the recurrence of symptoms.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 33 Reviews
7.7
9.5
Dizziness relieved
I've been taking it for four months. The capsules are easy to swallow, and I’m addressing my vitamin D3 deficiency. Dizziness has passed, though my joints still crunch. I recommend 5000 IU D3 for those with low levels.
9.5
Dizziness completely gone
In my late fifties and not seeing enough sun in Singapore, I initially tried a lower dose of vitamin D with no results. After switching to 5000 IU, my dizziness completely disappeared and my joints feel better.
9.5
Dizziness improved
After four months of taking it, I feel great. My dizziness has improved, and my sleep pattern has normalised. I recommend 5000 IU D3 for low levels.
9.5
Dizziness improved greatly
I had a vitamin D deficiency level of 8 in April, which improved to 50 after two months of taking it. I’m delighted and continue taking it daily.
9.5
Dizziness almost vanished
I’ve taken it daily for about a year at 5000 units. My health has significantly improved. Dizziness has almost vanished, and I wake up feeling refreshed, plus I rarely get colds now.
